• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维甲酸诱导基因1与神经精神疾病:一项系统综述

Retinoic Acid-Induced 1 Gene and Neuropsychiatric Diseases: A Systematic Review.

作者信息

Yang Tianmi, Pang Dejiang, Li Chunyu, Shang Huifang

机构信息

Department of Neurology, West China Hospital, Sichuan University, Sichuan, China.

Laboratory of Neurodegenerative Disorders, West China Hospital, https://ror.org/007mrxy13Sichuan University, Sichuan, China.

出版信息

Expert Rev Mol Med. 2025 May 29;27:e17. doi: 10.1017/erm.2025.12.

DOI:10.1017/erm.2025.12
PMID:40437981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12133160/
Abstract

BACKGROUND

Retinoic acid-induced 1 () is a dosage-sensitive gene implicated in a range of rare neuropsychiatric diseases.

METHODS

This review provides a comprehensive overview of role, integrating both clinical and basic research on Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome (PTLS) while also summarising research progress on its involvement in spinocerebellar ataxia (SCA), autism spectrum disorder (ASD), schizophrenia, bipolar disorder and major depression. A systematic review of the literature was conducted using PubMed and EMBASE, following the PRISMA guidelines, with the protocol registered in PROSPERO (CRD42023474165).

RESULTS

A total of 99 eligible studies on were included. We presented detailed characterisations of SMS and PTLS patients, emphasising the crucial role of haploinsufficiency and overexpression in their pathogenesis. Additionally, we summarised research progress on in SCA, ASD, schizophrenia, bipolar disorder and major depression. Integrating findings from animal studies, particularly those examining the regulatory mechanisms of in critical phenotypes, such as body weight, sleep and epilepsy, underscores the precise regulation of expression in maintaining various nervous system functions.

CONCLUSIONS

Overall, this review contributes to the identification of -related neuropsychiatric diseases, with a particular emphasis on enhancing clinical diagnosis of SMS and PTLS in developing countries.

摘要

背景

维甲酸诱导基因1()是一个剂量敏感基因,与一系列罕见的神经精神疾病有关。

方法

本综述全面概述了该基因的作用,整合了关于史密斯-马吉尼斯综合征(SMS)和波托基-卢普斯基综合征(PTLS)的临床和基础研究,同时总结了其在脊髓小脑共济失调(SCA)、自闭症谱系障碍(ASD)、精神分裂症、双相情感障碍和重度抑郁症中的研究进展。按照PRISMA指南,使用PubMed和EMBASE对文献进行了系统综述,方案已在PROSPERO(CRD42023474165)中注册。

结果

共纳入了99项关于该基因的合格研究。我们详细描述了SMS和PTLS患者的特征,强调了该基因单倍剂量不足和过表达在其发病机制中的关键作用。此外,我们总结了该基因在SCA、ASD、精神分裂症、双相情感障碍和重度抑郁症中的研究进展。整合动物研究的结果,特别是那些研究该基因在体重、睡眠和癫痫等关键表型中的调控机制的研究,强调了该基因表达的精确调控在维持各种神经系统功能中的重要性。

结论

总体而言,本综述有助于识别与该基因相关的神经精神疾病,特别强调加强发展中国家对SMS和PTLS的临床诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adc/12133160/9c27438f82c2/S1462399425000122_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adc/12133160/c6b734d47f59/S1462399425000122_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adc/12133160/9c27438f82c2/S1462399425000122_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adc/12133160/c6b734d47f59/S1462399425000122_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adc/12133160/9c27438f82c2/S1462399425000122_fig2.jpg

相似文献

1
Retinoic Acid-Induced 1 Gene and Neuropsychiatric Diseases: A Systematic Review.维甲酸诱导基因1与神经精神疾病:一项系统综述
Expert Rev Mol Med. 2025 May 29;27:e17. doi: 10.1017/erm.2025.12.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
6
Memantine for autism spectrum disorder.美金刚治疗自闭症谱系障碍。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD013845. doi: 10.1002/14651858.CD013845.pub2.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.成人慢性疼痛的体力活动与锻炼:Cochrane系统评价综述
Cochrane Database Syst Rev. 2017 Apr 24;4(4):CD011279. doi: 10.1002/14651858.CD011279.pub3.
9
Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.成人慢性疼痛的体力活动与锻炼:Cochrane系统评价概述
Cochrane Database Syst Rev. 2017 Jan 14;1(1):CD011279. doi: 10.1002/14651858.CD011279.pub2.
10
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.

本文引用的文献

1
Novel :c.2736delC Variant in Smith-Magenis Syndrome: Identification by Whole Genome Sequencing and Joint Analysis.新型:c.2736delC变异体与史密斯-马吉尼斯综合征:通过全基因组测序和联合分析鉴定
J Pers Med. 2024 Aug 25;14(9):901. doi: 10.3390/jpm14090901.
2
Case Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease.病例报告:一例 Smith-Magenis 综合征伴早发性帕金森病患者。
Int J Mol Sci. 2024 Aug 2;25(15):8447. doi: 10.3390/ijms25158447.
3
Genome-wide DNA methylation analysis related to ALS patient progression and survival.
全基因组 DNA 甲基化分析与 ALS 患者的进展和生存相关。
J Neurol. 2024 May;271(5):2672-2683. doi: 10.1007/s00415-024-12222-6. Epub 2024 Feb 19.
4
Comparative analyses of the Smith-Magenis syndrome protein RAI1 in mice and common marmoset monkeys.比较分析 Smith-Magenis 综合征蛋白 RAI1 在小鼠和普通狨猴中的作用。
J Comp Neurol. 2024 Jan;532(1):e25589. doi: 10.1002/cne.25589.
5
Pentanucleotide Repeat Insertions in RAI1 Cause Benign Adult Familial Myoclonic Epilepsy Type 8.RAI1 中的五核苷酸重复插入导致良性成人家族性肌阵挛癫痫 8 型。
Mov Disord. 2024 Jan;39(1):164-172. doi: 10.1002/mds.29654. Epub 2023 Nov 22.
6
Smith-Magenis syndrome protein RAI1 regulates body weight homeostasis through hypothalamic BDNF-producing neurons and neurotrophin downstream signalling.Smith-Magenis 综合征蛋白 RAI1 通过下丘脑产生 BDNF 的神经元和神经营养因子下游信号调节体重稳态。
Elife. 2023 Nov 13;12:RP90333. doi: 10.7554/eLife.90333.
7
Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review.患有史密斯-马吉尼斯综合征的成年人的精神和神经学表现:一项范围综述。
Am J Med Genet B Neuropsychiatr Genet. 2024 Mar;195(2):e32956. doi: 10.1002/ajmg.b.32956. Epub 2023 Aug 16.
8
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome.视黄酸诱导的 1 号基因单倍剂量不足改变脂质代谢,导致 Smith-Magenis 综合征发生自噬缺陷。
Cell Death Dis. 2022 Nov 21;13(11):981. doi: 10.1038/s41419-022-05410-7.
9
rAAV-CRISPRa therapy corrects Rai1 haploinsufficiency and rescues selective disease features in Smith-Magenis syndrome mice.rAAV-CRISPRa 疗法纠正 Rai1 杂合不足并挽救 Smith-Magenis 综合征小鼠的选择性疾病特征。
J Biol Chem. 2023 Jan;299(1):102728. doi: 10.1016/j.jbc.2022.102728. Epub 2022 Nov 19.
10
Genomic architecture of autism from comprehensive whole-genome sequence annotation.自闭症的全基因组序列注释的基因组结构。
Cell. 2022 Nov 10;185(23):4409-4427.e18. doi: 10.1016/j.cell.2022.10.009.